Promising Glioma Therapy Options
Dr. James Perry speaks withCancer Network about glioma therapy options and the future of brain cancer treatment. (Source: CancerNetwork)
Source: CancerNetwork - December 22, 2018 Category: Cancer & Oncology Authors: James Perry, MD Source Type: news
AR improves operative view for robotic thyroid surgery
Researchers from South Korea have developed a technique to enhance the safety...Read more on AuntMinnie.comRelated Reading:
AR, 3D printing make headway in patient education
Virtual reality may help plan, guide glioma resection
Augmented reality heightens accuracy of brain procedure
Augmented reality guides orthopedic surgery
SIR: Holography platform boosts reader confidence for aneurysms (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2018 Category: Radiology Source Type: news
FDA to review Blue Earth's Axumin for brain cancer
The U.S. Food and Drug Administration (FDA) has accepted molecular imaging...Read more on AuntMinnie.comRelated Reading:
Blue Earth study reports Axumin can aid glioma diagnosis
Blue Earth promotes results for PET/CT agent
Blue Earth expands PSMA-PET/CT imaging portfolio
Blue Earth touts addition of Axumin to NCCN guidelines
Blue Earth highlights Axumin clinical results at ASTRO (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2018 Category: Radiology Source Type: news
'Don't come back and don't bring any friends!' Cancer patient waves goodbye to his brain tumour
James Hinnigan, 39, of Wigan, Greater Manchester, underwent pioneering surgery to remove his stage two glioma while taking part in a clinical trial at Charing Cross Hospital in 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - December 6, 2018 Category: Consumer Health News Source Type: news
Liquid Biopsy Can Assess Tx Response of Peds Brain Tumors
THURSDAY, Nov. 29, 2018 -- A liquid biopsy using blood or cerebrospinal fluid (CSF) can effectively quantify changes in mutation levels among pediatric patients being treated for diffuse midline gliomas (DMGs), according to a study recently... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2018 Category: Pharmaceuticals Source Type: news
Brain tumor patient, 5, astonishes doctors by walking and talking
Rebecca Roper, five, from Enid, Oklahoma, was diagnosed with a tumor known as a glioma on her brainstem in summer 2017. Doctors were unsure if she would ever walk again. (Source: the Mail online | Health)
Source: the Mail online | Health - November 26, 2018 Category: Consumer Health News Source Type: news
Blue Earth study reports Axumin can aid glioma diagnosis
Molecular imaging firm Blue Earth Diagnostics presented new results from a...Read more on AuntMinnie.comRelated Reading:
Blue Earth promotes results for PET/CT agent
Blue Earth expands PSMA-PET/CT imaging portfolio
Blue Earth touts addition of Axumin to NCCN guidelines
Blue Earth highlights Axumin clinical results at ASTRO
Blue Earth touts Axumin reader training results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2018 Category: Radiology Source Type: news
New drug discovery could halt spread of brain cancer
(Virginia Tech) A team of researchers at Virginia Tech may have found a solution to stopping the spread of glioblastoma with a new drug and cancer treatment method. This work is part of a five-year research grant project across multiple universities, examining the role of interstitial fluid flow in spreading glioma cells through the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2018 Category: International Medicine & Public Health Source Type: news
Do Bigger Brains Contribute to More Cancer?
New research published inNeuro-Oncology examines the controversial link between intracranial volume and high-grade glioma. (Source: CancerNetwork)
Source: CancerNetwork - November 16, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
Cognitive decline -- radiation -- brain tumor prevented by temporarily shutting down immune response
(University of California - San Francisco) In a new study published Nov. 13 in the journal eLife, UC San Francisco scientists report the first animal model of glioma -- the most aggressive and most common form of brain cancer in the US -- that can also be used to study the long-term effects of radiation therapy in tumor-bearing brains. Using this mouse model, the researchers showed that a drug that temporarily suppresses a key component of the brain's immune system can prevent radiation-associated cognitive decline. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2018 Category: International Medicine & Public Health Source Type: news
Fluorescence Can ID High - Grade Glioma During Sx for Brain Tumor
Visible fluorescence shows presence of high - grade glioma cells within tumor mass during surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 6, 2018 Category: Cancer & Oncology Tags: Neurology, Oncology, Pathology, Radiology, Surgery, Conference News, Source Type: news
Fluorescence Can ID High-Grade Glioma During Sx for Brain Tumor
TUESDAY, Nov. 6, 2018 -- The presence of visible fluorescence can serve as an intraoperative diagnostic surgical biomarker of high-grade glioma within a brain tumor, according to a study presented at the 2018 National Cancer Research Institute... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 6, 2018 Category: Pharmaceuticals Source Type: news
Liquid Biopsy May Reveal Treatment Response in Pediatric Brain Tumors Liquid Biopsy May Reveal Treatment Response in Pediatric Brain Tumors
In children with diffuse midline glioma (DMG), liquid biopsy based on analyses of circulating tumor DNA (ctDNA) in cerebral spinal fluid (CSF) or plasma shows promise for detecting mutational load and may serve as tool for assessing tumor response to treatment, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 17, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Human Brain Microvascular Endothelial Cell in Action
Recent PubsOur HumanBrain Microvascular Endothelial Cells (HBMECs) are known for the performance in drug discovery and tox assays. These 21-CFR compliant cells are used in the " blood side " of our3-D BBB Models.Shavali Shaik, Bridget Kennis, Shinji Maegawa, Keri Schadler, Yang Yanwen, Keri Callegari, Rishi R. Lulla, Stewart Goldman, Javad Nazarian, Veena Rajaram, Jason Fangusaro, and Vidya Gopalakrishnan. (2018).REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature. Oncotarget. 2018 Jan 12; 9(4): 5233 –5250. doi: 10.18632/oncotarget.23750 Hu et al. (2016). Epigenetic Activation of WNT5A ...
Source: Neuromics - September 20, 2018 Category: Neuroscience Tags: Blood Brain Barrier Blood Brain Barrier Models brain microvascular endothelial cells HBMECs human brain microvascular Source Type: news
